The legacy of Viagra and its originator, copyright, presents a complex picture for potential investors. While the blockbuster drug initially generated enormous revenues , its protection has lapsed , leading to generic options flooding the arena. This reduction in cost presents a significant obstacle for copyright and any company considering a large